LI-COR Biotech: Odyssey M Chemi/Fluor Imaging Bundle Standard

The U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute (NCI) Center for Cancer Research (CCR) has issued this sources sought notice under solicitation number SSN75N91026Q00013. The NCI requires one new, commercially available Odyssey M Chemi/Fluor Imaging Bundle Standard to replace an outdated protein imager. This versatile system is intended for shared use across the laboratory branch and division to support ongoing and future intramural research projects through simplified imaging workflows.

The Odyssey M provides a variety of applications for research initiatives, including fluorescent and colorimetric Western blots, immunocytochemistry such as In-Cell and On-Cell Western assays, and Enzyme-Linked Immunosorbent Assays. The system further supports protein and nucleic acid arrays, high-resolution fluorescent and Red/Green/Blue tissue section analysis, and both fluorescent and colorimetric protein gel detection. Additionally, the equipment facilitates nucleic acid detection and non-isotopic Electrophoretic Mobility Shift Assays.

Responses to this notice are due by May 27, 2026. The primary place of performance is Bethesda, MD, and Shayna Simpson serves as the point of contact for the Office of the Assistant Secretary for Administration. One attachment, a Sources Sought Notice PDF, was published on May 21, 2026, alongside the initial notice.